Written from the studies on PubMed, searched on 11 Nov 2026. Every number below comes from a study listed under Sources.
The claim
Posts online say that CBD (cannabidiol) helps with chronic myeloid leukaemia.
Where research stands
We found 5 published papers on CBD (cannabidiol) and chronic myeloid leukaemia. They were published between 2022 and 2026. None of them is a study in people. None was a study in animals, and 4 were only in cells in the lab. 1 paper is a review that sums up other studies.
- 0In people
- 0In animals
- 4Only in the lab
What the studies found
We have not summed up these studies in words yet. The most important papers are listed under Sources.
Verdict
CBD (cannabidiol) has been studied for chronic myeloid leukaemia only in cells in the lab.
Unproven means: it was only tested in animals or cells, or there is too little or mixed data from people. How we rate claims
What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- [Pharmaceutical interviews in onco-haematology and so-called 'natural' products: An example illustrated by cannabidiol (CBD)].2026 · Bull Cancer · Review
- Cannabidiol modulates exosomal miRNA networks to enhance Imatinib mesylate response in chronic myelogenous leukemia.2026 · Glob Med Genet · In the lab
- Bioinformatics differential expression analysis of the effect of cannabidiol in chronic myeloid leukaemia cell line.2025 · Glob Med Genet · In the lab
- A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells.2024 · Heliyon · In the lab
- The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib.2022 · Cancer Sci · In the lab
